BioPlus ApS: Financial statements 2019
CVR: 37630683
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
BioPlus ApS (CVR 37630683) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -112,409 and a net result of DKK -117,681 compared with DKK 126,128 the year before. Equity in the 2019 report amounted to DKK 59,391. The solvency ratio was 62.4%.
- Gross Profit
- DKK -112,409
- Profit/Loss
- DKK -117,681
- Equity
- DKK 59,391
- Total Assets
- DKK 95,232
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -112 t. | -118 t. | 59 t. | - |
| 2018 | - | 200 t. | 126 t. | 177 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout BioPlus ApS
BioPlus ApS was a Danish company of the type Anpartsselskab based in Kastrup, founded in 2016. The company has been dissolved on 26 January 2022. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2019, the company reported a gross profit of DKK -112,409 and a net result of DKK -117,681 compared with DKK 126,128 the year before. Equity in the 2019 report amounted to DKK 59,391.